Misa ukunqunywa kwama-statins, ezetimibe kanye ne-PCSK9-i ngokwemithetho ye-AIFA
Usizo lukadokotela ukuze athole ukugunyazwa kwezidakamizwa ezilwa ne-dyslipidemic e-Italy
ISIGABA SOKU-1: Umhlahlandlela wokunikezwa kwemithi kanye/noma i-ezetimibe ngokusekelwe ekuhlukaniseni ubungozi, ngokuya nge-AIFA QAPHELA 13.
ISIGABA SESI-2: Ukusungula ukufaneleka kweziguli ukuthola ukwelashwa nge-PCSK9 protein inhibitors (evolocumab ne-alirocumab), ngokusekelwe ezinhlinzekweni ze-Italian Medicines Agency (AIFA).
Kubuyekezwe ngo-
Jan 12, 2025